medisourceasia.com

Industry News


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Manufacturers Welcome Price Cap On Medical Devices

The Association of Indian Medical Device Industry, which represents domestic manufacturers, has welcomed the government proposal to extend price caps to devices including catheters and balloons which are used in angioplasties.

A government panel has recommended inclusion of these devices under price control following complaints of overcharging by hospitals. The National Pharmaceutical Pricing Authority requested the government to classify balloons and catheters as drugs and include them under the National List of Essential Medicines.

The government had in February capped the price of stents by around 85 per cent. The move resulted in increased sales for domestic manufacturers which are supporting more such actions.

A decision to extend price cap on other devices is expected to hurt hospitals and impact their margins. Though some large chains believe price caps could have a short-term impact, given their service diversification, there is displeasure in the private healthcare service providers over the government action.

“Pressure has increased on India to revise its stance on price caps for medical devices and not to extend it to other devices. But the government should do what is good for the country and give advantage to common citizens who now have access to the best products at the most affordable prices and to domestic manufacturers,” said Rajiv Nath, forum co-ordinator, AiMeD.

“In the last six months we have seen a positive trend towards increased sales for domestic manufacturers. We estimate the trend to continue and Indian manufacturers will grab 60 per cent of market share by next year,” Nath said.

Earlier this year the Maharashtra Food and Drug Administration had examined invoices in 12 major hospitals in the state and found that over 70 per cent of the cost paid for balloon catheters by patients is profit margin of manufacturers, distributors and hospitals. In case of guiding catheters more than 47 per cent of the cost paid by patients was found to be profit margin of these three stakeholders.

(Ref : Business Standard dated October 12, 2017)


Gujarat Registers Maximum Number Of 170 Medical Devices Units In The Country Under CLAA Scheme

Gujarat as of today has registered the maximum number of 170 licensed medical device units under the Central Licensing Approval Authority (CLAA) scheme as against a total of 284 medical device units in the entire country. The state had 150 such high end medical device units 11 months back and has also granted licenses to 56 new drug manufacturing units.

The devices currently regulated under CLAA scheme include cardiac stents, drug eluting stents, catheters, intra ocular lenses, I.V. Cannula, bone cements, heart valves, scalp vein set, orthopaedic implants and internal prosthetic replacements.

CLAA has been formed to oversee the regulatory activities related to grant of manufacturing license for hi-tech medical devices in India. It aims at ensuring that the medical devices being manufactured in India follow the standard requirements set by the government to ensure safety, efficacy and quality of the devices.

The Centre has also been mulling for quite some time for setting up the medical devices park in Gujarat in a bid to make India self-reliant in the sector. The creation of manufacturing park for medical devices will boost the segment of hi-tech medical devices as medical devices manufacturing requires certain high investment facilities which are too capital intensive for individual manufacturers to invest upon. A park with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 percent.

This will also help facilitate to create an ecosystem for manufacturing of high end medical device manufacturing aimed at import substitution and export opportunities and would be a major boost to SMEs.

(Ref : http://www.pharmabiz.com/NewsDetails.aspx?aid=104308&sid=1  (September 18, 2017 )

Other News

MTaI Puts Forward Key Recommendations To Govt For More Enabling Environment For Medical Devices Industry In India
Gujarat FDCA Writes To Health Ministry To Accelerate Process of Setting Up Much Awaited Medical Device Testing Lab At Vadodara

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next